公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2004 | Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA | Huang L.-R.; Chiu C.-M.; Shiou-Hwei Yeh ; Huang W.-H.; PO-REN HSUEH ; Yang W.-Z.; Yang J.-Y.; Su I.-J.; SHAN-CHWEN CHANG ; PEI-JER CHEN | Journal of Medical Virology | 58 | 54 | |
2018 | Evaluation of SH-SAW Biosensor in Whole Blood | Kano K.; Huang Y.-Q.; Kogai T.; Huang Y.-T.; Yatsuda H.; PEI-JER CHEN ; Liu S.-H. | IEEE International Ultrasonics Symposium, IUS | 2 | 0 | |
1995 | Evaluation of third-generation hepatitis C antibody assay in chronic hepatitis C and chronic non-B, non-C hepatitis | JIA-HORNG KAO ; PEI-MING YANG ; Lai M.-Y.; PEI-JER CHEN ; Wang T.-H.; DING-SHINN CHEN | Viral Immunology | 3 | 2 | |
2009 | Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study | WEI-LIANG SHIH ; MING-WHEI YU ; PEI-JER CHEN ; Wu T.-W.; Lin C.-L.; CHUN-JEN LIU ; Lin S.-M.; Tai D.-I.; Lee S.-D.; Liaw Y.-F. | European Journal of Human Genetics | 19 | 17 | |
2020 | Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals | CHEN-HUA LIU ; Lee M.-H.; JOU-WEI LIN ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 41 | 43 | |
2021 | Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy | CHEN-HUA LIU ; HSIN-YUN SUN ; SZU-MIN HSIEH ; Liu W.-C.; WANG-HUEI SHENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Journal of Viral Hepatitis | 6 | 6 | |
2007 | Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy | WANG-HUEI SHENG ; JIA-HORNG KAO ; PEI-JER CHEN ; LI-MIN HUANG ; SUI-YUAN CHANG ; HSIN-YUN SUN ; CHIEN-CHING HUNG ; Chen M.-Y.; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 72 | 66 | |
2006 | Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C | Chen B.-F.; CHUN-JEN LIU ; Jow G.-M.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of General Virology | 32 | 28 | |
2004 | Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy | Lin C.-L.; Liao L.-Y.; Wang C.-S.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 16 | 23 | |
1997 | Evolution of hepatitis C virus quasispecies in mothers and infants infected through mother-to-infant transmission | YEN-HSUAN NI ; MEI-HWEI CHANG ; PEI-JER CHEN ; HO-HSIUNG LIN ; HONG-YUAN HSU | Journal of Hepatology | 40 | 38 | |
2004 | Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Medical Virology | 24 | 21 | |
2010 | The evolution of real-time PCR machines to real-time PCR chips | Lee D.; PEI-JER CHEN ; Lee G.-B. | Biosensors and Bioelectronics | 31 | 26 | |
2018 | Exploring new therapies for a serological cure of chronic hepatitis B | Horng J.-H.; Wu C.-R.; PEI-JER CHEN | Hepatitis B Virus and Liver Disease | 0 | 0 | |
2019 | Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma | Li Y.-T.; Wu H.-L.; JIA-HORNG KAO ; Cheng H.-R.; MING-CHIH HO ; Wang C.-C.; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology | 7 | 7 | |
2009 | Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 33 | 30 | |
2000 | Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives | MING-WHEI YU ; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; CHUN-JEN LIU ; PEI-JER CHEN ; Hsiao T.-J.; PO-HUANG LEE ; Chen C.-J. | Journal of the National Cancer Institute | 210 | 183 | |
2015 | Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity | Huang M.-T.; Liu W.-L.; CHUN-WEI LU ; Huang J.-J.; Chuang H.-L.; Huang Y.-T.; Horng J.-H.; Liu P.; Han D.-S.; BOR-LUEN CHIANG ; Shih C.; PEI-JER CHEN ; Chen D.-S. | European Journal of Immunology | 10 | 10 | |
1994 | Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation | CHIEN-HUNG CHEN ; PEI-JER CHEN ; Chu J.-S.; KUN-HUEI YEH ; Lai M.-Y.; DING-SHINN CHEN | Gastroenterology | 69 | 55 | |
2017 | Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 42 | 39 | |
2018 | Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 19 | 18 |